Related references
Note: Only part of the references are listed.Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis
Jae-Won Hyun et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
Dejan Jakimovski et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Novel Markers for Predicting Type 2 Neurologic Complications of Coronary Artery Bypass Grafting
Krzysztof Szwed et al.
ANNALS OF THORACIC SURGERY (2020)
Postoperative delirium is associated with increased plasma neurofilament light
Cameron P. Casey et al.
BRAIN (2020)
Fluctuations in blood biomarkers of head trauma in NCAA football athletes over the course of a season
Jonathan M. Oliver et al.
JOURNAL OF NEUROSURGERY (2019)
Performance Evaluation of a Multiplex Assay for Simultaneous Detection of Four Clinically Relevant Traumatic Brain Injury Biomarkers
Frederick K. Korley et al.
JOURNAL OF NEUROTRAUMA (2019)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
B. Gille et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Catherine Owens Johnson et al.
LANCET NEUROLOGY (2019)
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Jens Kuhle et al.
NEUROLOGY (2019)
Serum NFL discriminates Parkinson disease from atypical parkinsonisms
Taina M. Marques et al.
NEUROLOGY (2019)
The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study
Johannes Ehler et al.
PLOS ONE (2019)
Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism
Radu Constantinescu et al.
ACTA NEUROLOGICA SCANDINAVICA (2019)
Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?
Thaleia Kalatha et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders
Sara Mariotto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury
Eric Thelin et al.
JOURNAL OF NEUROTRAUMA (2019)
Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke
Juha Onatsu et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease
Lijun Peng et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS
Alfredo Damasceno et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
Carlo Wilke et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathy
Giulio Disanto et al.
EPILEPSY & BEHAVIOR (2019)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Claire Bridel et al.
JAMA NEUROLOGY (2019)
A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients
Thomas Saller et al.
BIOMEDICAL PAPERS-OLOMOUC (2019)
Prognostic factors for the sequelae and severity of Guillain-Barre syndrome in children
Sophie Estrade et al.
MUSCLE & NERVE (2019)
Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
Kazuhito Mietani et al.
PLOS ONE (2019)
Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction
Annie Pedersen et al.
JOURNAL OF NEUROLOGY (2019)
Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naive relapsing MS patients
Tobias Sejbaek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Post-stroke inflammation-target or tool for therapy?
Kate Lykke Lambertsen et al.
ACTA NEUROPATHOLOGICA (2019)
Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS
Irene Hakansson et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
NFL blood levels are moderated by subconcussive impacts in a cohort of college football players
Leah H. Rubin et al.
BRAIN INJURY (2019)
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
Federico Verde et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury
Iftakher Hossain et al.
JOURNAL OF NEUROTRAUMA (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest
Marion Moseby-Knappe et al.
JAMA NEUROLOGY (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
Emily Feneberg et al.
NEUROLOGY (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barre syndrome: A pilot study
M. Axelsson et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2018)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
Serum neurofilament light chain in patients with acute cerebrovascular events
G. M. De Marchis et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Irene Hakansson et al.
JOURNAL OF NEUROINFLAMMATION (2018)
! Longitudinal Performance of Plasma Neurofilament Light and Tau in Professional Fighters: The Professional Fighters Brain Health Study
Charles Bernick et al.
JOURNAL OF NEUROTRAUMA (2018)
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies
Sara Mariotto et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2018)
Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
Lieke H. H. Meeter et al.
NEUROLOGY (2018)
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
Asa Sandelius et al.
NEUROLOGY (2018)
Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers
Lenka Novakova et al.
PLOS ONE (2018)
Multiple sclerosis biomarkers: Helping the diagnosis?
E. Thouvenot
REVUE NEUROLOGIQUE (2018)
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
Andre Strydom et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
Ross W. Paterson et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine
O. Yildiz et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
Marco Duering et al.
JOURNAL OF STROKE (2018)
Recent Advances in Pathophysiology of Traumatic Brain Injury
Parmeet Kaur et al.
CURRENT NEUROPHARMACOLOGY (2018)
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Juan Fortea et al.
LANCET NEUROLOGY (2018)
Neurofilaments and 10-year follow-up in multiple sclerosis
Alok Bhan et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Serum neurofilament light A biomarker of neuroaxonal injury after ischemic stroke
Steffen Tiedt et al.
NEUROLOGY (2018)
Serum neurofilament light chain in behavioral variant frontotemporal dementia
Petra Steinacker et al.
NEUROLOGY (2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M. Byrne et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study
Shoji Yokobori et al.
SCIENTIFIC REPORTS (2018)
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease
Piotr Lewczuk et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease
Umesh Gangishetti et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Peter A. Ljubenkov et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study
Samir Abu-Rumeileh et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
Yung-Shuan Lin et al.
SCIENTIFIC REPORTS (2018)
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease
Raquel Sanchez-Valle et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of Inflammation
Marc Pawlitzki et al.
FRONTIERS IN NEUROLOGY (2018)
CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
Marc Pawlitzki et al.
FRONTIERS IN NEUROLOGY (2018)
Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis
Tanuja Chitnis et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics
Colin Wallace et al.
BMJ OPEN SPORT & EXERCISE MEDICINE (2018)
Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy
Antje Bischof et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Neurofilament Light in Serum and Cerebrospinal Fluid of Hip Fracture Patients with Delirium
Nathalie Bodd Halaas et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2018)
Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
Laisheng Cai et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
J. Mellergard et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net
Petra Steinacker et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis
Zhang-Yu Zou et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Lauren M. Byrne et al.
LANCET NEUROLOGY (2017)
Serum neurofilament light is sensitive to active cerebral small vessel disease
Thomas Gattringer et al.
NEUROLOGY (2017)
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Lenka Novakova et al.
NEUROLOGY (2017)
Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder
Oskar Hansson et al.
NEUROLOGY (2017)
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
Pashtun Shahim et al.
NEUROLOGY (2017)
Plasma neurofilament light chain levels in Alzheimer's disease
Wenjun Zhou et al.
NEUROSCIENCE LETTERS (2017)
Chronic Traumatic Encephalopathy Known Causes, Unknown Effects
Diego Iacono et al.
PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA (2017)
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
Tobias Skillback et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2017)
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis Neurofilament Light Chain Levels in Definite Subtypes of Disease
Alessandra Gaiani et al.
JAMA NEUROLOGY (2017)
Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
Valter Niemela et al.
PLOS ONE (2017)
Biomarkers for Alzheimer's Disease Diagnosis
Vasileios Mantzavinos et al.
CURRENT ALZHEIMER RESEARCH (2017)
Omic and Systems Biology Approaches in Neurodegenerative Diseases Applying fluid biomarkers to Alzheimer's disease
Henrik Zetterberg
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)
Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies
Lih-Fen Lue et al.
NEUROLOGY AND THERAPY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models
Elizabeth E. Spangenberg et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy
Ann C. McKee et al.
ACTA NEUROPATHOLOGICA (2016)
Neurofilament Levels as Biomarkers in Asymptomatic and Symptomatic Familial Amyotrophic Lateral Sclerosis
Patrick Weydt et al.
ANNALS OF NEUROLOGY (2016)
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Petra Steinacker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
Bettina Hjelm Clausen et al.
ACTA NEUROPATHOLOGICA (2016)
Stroke: a global response is needed
Walter Johnson et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2016)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Jens Kuhle et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Serum Neurofilament Light in American Football Athletes over the Course of a Season
Jonathan M. Oliver et al.
JOURNAL OF NEUROTRAUMA (2016)
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
Sara Hall et al.
MOVEMENT DISORDERS (2016)
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Traumatic brain injuries
Kaj Blennow et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
Magnus Gisslen et al.
EBIOMEDICINE (2016)
Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling
Bettina Hjelm Clausen et al.
SCIENTIFIC REPORTS (2016)
Cerebrospinal Fluid Biomarkers for Huntington's Disease
Lauren M. Byrne et al.
JOURNAL OF HUNTINGTONS DISEASE (2016)
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease
Tua Vinther-Jensen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
Joakim Bergman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Neurofilament dynamics and involvement in neurological disorders
Benoit J. Gentil et al.
CELL AND TISSUE RESEARCH (2015)
Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection
Christopher Traenka et al.
CEREBROVASCULAR DISEASES (2015)
Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury
Eduardo Martinez-Morillo et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Biomarkers in multiple sclerosis
William J. Housley et al.
CLINICAL IMMUNOLOGY (2015)
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
N. K. Magdalinou et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis
P. A. McCombe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Frances K. Wiseman et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
CSF neurofilament light chain but not FLT3 ligand discriminates parkinsonian disorders
Megan K. Herbert et al.
FRONTIERS IN NEUROLOGY (2015)
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
Jens Kuhle et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Monitoring concussion in a knocked-out boxer by CSF biomarker analysis
Sanna Neselius et al.
KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY (2015)
Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light
Faiez Al Nimer et al.
PLOS ONE (2015)
No effect of ablation of surfactant protein-D on acute cerebral infarction in mice
Kate L. Lambertsen et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Body fluid biomarkers in multiple sclerosis
Manuel Comabella et al.
LANCET NEUROLOGY (2014)
Cerebrospinal fluid biomarkers in cardiac arrest survivors
Christoffer Rosen et al.
RESUSCITATION (2014)
Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases
Seyed A. Sajjadi et al.
BRAIN (2013)
Consensus Statement on Concussion in Sport: The 4th International Conference on Concussion in Sport, Zurich, November 2012
Paul McCrory et al.
JOURNAL OF ATHLETIC TRAINING (2013)
Assessment of Global and Regional Diffusion Changes along White Matter Tracts in Parkinsonian Disorders by MR Tractography
Yulia Surova et al.
PLOS ONE (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis
Signe Modvig et al.
PLOS ONE (2013)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Neurofilaments at a glance
Aidong Yuan et al.
JOURNAL OF CELL SCIENCE (2012)
Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging
Kazumichi Tsukamoto et al.
NEURORADIOLOGY (2012)
CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma
Sanna Neselius et al.
PLOS ONE (2012)
Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest
Malin Rundgren et al.
CRITICAL CARE (2012)
Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage
E. R. Zanier et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke
P. Singh et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Hyperacute Detection of Neurofilament Heavy Chain in Serum Following Stroke: A Transient Sign
Johann Sellner et al.
NEUROCHEMICAL RESEARCH (2011)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study
M. Jonsson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
David M. Rissin et al.
NATURE BIOTECHNOLOGY (2010)
Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders
Radu Constantinescu et al.
PARKINSONISM & RELATED DISORDERS (2010)
Neurofilament subunit (NFL) head domain phosphorylation regulates axonal transport of neurofilaments
Darran M. Yates et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
Mitochondrial and Axonal Abnormalities Precede Disruption of the Neurofilament Network in a Model of Charcot-Marie-Tooth Disease Type 2E and Are Prevented by Heat Shock Proteins in a Mutant-Specific Fashion
Miranda L. Tradewell et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Neurologic Prognosis after Cardiac Arrest
G. Bryan Young
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease
Radu Constantinescu et al.
PARKINSONISM & RELATED DISORDERS (2009)
Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysmal subarachnoid hemorrhage patients
Stephen B. Lewis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Glial and Axonal Body Fluid Biomarkers Are Related to Infarct Volume, Severity, and Outcome
Axel Petzold et al.
Journal of Stroke & Cerebrovascular Diseases (2008)
Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration
Rodolphe Perrot et al.
MOLECULAR NEUROBIOLOGY (2008)
Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1
Jinbin Zhai et al.
HUMAN MOLECULAR GENETICS (2007)
Huntington's disease phenocopy syndromes
Edward J. Wild et al.
CURRENT OPINION IN NEUROLOGY (2007)
No neurochemical evidence for brain injury caused by heading in soccer
Henrik Zetterberg et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2007)
Plasma neurofilament heavy chain levels in Huntington's disease
Edward J. Wild et al.
NEUROSCIENCE LETTERS (2007)
CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease
W. Farid Abdo et al.
NEUROBIOLOGY OF AGING (2007)
Neurochemical aftermath of amateur boxing
Henrik Zetterberg et al.
ARCHIVES OF NEUROLOGY (2006)
Prevalence and patterns of cognitive impairment in sporadic ALS
GM Ringholz et al.
NEUROLOGY (2005)
The G336S variant in the human neurofilament-M gene does not affect its assembly or distribution: Importance of the functional analysis of neurofilament variants
R Perez-Olle et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest
H Rosén et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma
M Guéz et al.
JOURNAL OF NEUROTRAUMA (2003)
Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation
R Perez-Olle et al.
JOURNAL OF CELL SCIENCE (2002)
Monoclonal antibodies selective for low molecular weight neurofilaments
N Norgren et al.
HYBRIDOMA AND HYBRIDOMICS (2002)
Share Paper
